Flyte

About Pelvital

Pelvital has developed and commercialized Flyte, a novel, prescription-only medical device for the non-surgical treatment of female stress urinary incontinence. The technology uses proprietary mechanotherapy—applying precise mechanical oscillations—to strengthen pelvic floor muscles through a 5-minute daily, 6-week at-home regimen. Backed by clinical data showing 82% continence rates, the company targets the massive, underserved market of women seeking alternatives to surgery or traditional pelvic floor exercises. Pelvital appears to be a private, commercial-stage company generating early revenue from direct-to-consumer and healthcare provider channels.

Therapeutic Areas